Table 2.
Parameter | Final model | Bootstrapa | |||
---|---|---|---|---|---|
Estimate | Median | RSE (%) | 95% CI | ||
CL/F, kL/day | 2.6 | 2.6 | 4.53 | (2.42–2.8) | |
V/F, kL | 14.4 | 14.4 | 12.1 | (11.9–17.6) | |
Ka, | 1.22 | 1.22 | 44.9 | (0.785–2.67) | |
, mg/day | 6.24 | 6.25 | 23.3 | (3.53–8.09) | |
|
1.18 | 1.43 | 55.9 | (0.43–2.74) | |
, mg/day | 12.5 | 12.3 | 25.2 | (7.75–18) | |
, IU/L | 12.9 | 12.7 | 63.1 | (0.892–23.7) | |
A_0, TC | 6.24 | 6.21 | 5.82 | (5.63–6.85) | |
|
−1.55 | −1.84 | 58.7 | (−3.56 to −0.842) | |
|
−0.27 | −0.27 | 25.4 | (−0.369 to −0.108) | |
|
1.71 | 1.77 | 36.7 | (0.776–2.98) | |
|
0.785 | 0.793 | 17.4 | (0.595–1.03) | |
|
0.016 | 0.016 | 45.2 | (0.00382–0.0254) | |
|
0.261 | 0.191 | 105 | (0.00261–0.839) | |
|
0.057 | 0.057 | 18.7 | (0.039–0.073) | |
IIV_CLb | 9.66% (25.2) | 8.60% | 57.3 | (2.98%–12.29%) | |
IIV_V | 37% (14.6) | 35.9% | 52.8 | (18.3%–51.7%) | |
IIV_Ka | 53.9% (42.5) | 52.4% | 89.7 | (0.54%–87.5%) | |
IIV_ | 45.3% (16.3) | 43.1% | 71.6 | (14.5%–66.3%) | |
IIV_ | 75.9% (25.3) | 72.9% | 47.4 | (40.0%–99.6%) | |
IIV_A_0, TC | 13.6% (49.6) | 13.3% | 77.1 | (0.14%–21.3%) |
CI, confidence interval; CL, clearance; E max, maximum effect; IIV, inter‐individual variability; RSE%, percentage of relative standard error; TC, testosterone cypionate; V, volume.
Median, RSE, and 95% CIs were calculated based on 500 nonparametric bootstrap results.
Shrinkage of IIV parameters was reported along with parameter estimates.